These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21844183)

  • 1. Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma.
    Li Y; Chen L; Nie CJ; Zeng TT; Liu H; Mao X; Qin Y; Zhu YH; Fu L; Guan XY
    Cancer Res; 2011 Oct; 71(19):6106-15. PubMed ID: 21844183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.
    Zhu C; Qin YR; Xie D; Chua DT; Fung JM; Chen L; Fu L; Hu L; Guan XY
    Oncogene; 2009 Aug; 28(31):2821-8. PubMed ID: 19525977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma.
    Fu L; Qin YR; Xie D; Hu L; Kwong DL; Srivastava G; Tsao SW; Guan XY
    Cancer Res; 2007 Nov; 67(22):10720-6. PubMed ID: 18006814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.
    Liang YN; Liu Y; Meng Q; Li X; Wang F; Yao G; Wang L; Fu S; Tong D
    Med Oncol; 2015 Feb; 32(2):459. PubMed ID: 25588924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.
    Kong KL; Kwong DL; Fu L; Chan TH; Chen L; Liu H; Li Y; Zhu YH; Bi J; Qin YR; Law SY; Guan XY
    Cancer Res; 2010 Nov; 70(21):8832-41. PubMed ID: 20978196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.
    Qin YR; Tang H; Xie F; Liu H; Zhu Y; Ai J; Chen L; Li Y; Kwong DL; Fu L; Guan XY
    Clin Cancer Res; 2011 Jan; 17(1):46-55. PubMed ID: 21084391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.
    Zhu YH; Fu L; Chen L; Qin YR; Liu H; Xie F; Zeng T; Dong SS; Li J; Li Y; Dai Y; Xie D; Guan XY
    Cancer Res; 2013 Apr; 73(7):2298-309. PubMed ID: 23436800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
    Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
    Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma.
    Fatima S; Chui CH; Tang WK; Hui KS; Au HW; Li WY; Wong MM; Cheung F; Tsao SW; Lam KY; Beh PS; Wong J; Law S; Srivastava G; Ho KP; Chan AS; Tang JC
    Int J Mol Med; 2006 Jan; 17(1):159-70. PubMed ID: 16328025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
    Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
    Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
    Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
    Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
    Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSP58 knockdown inhibits the proliferation of esophageal squamous cell carcinoma in vitro and in vivo.
    Xu CS; Zheng JY; Zhang HL; Zhao HD; Zhang J; Wu GQ; Wu L; Wang Q; Wang WZ; Zhang J
    Asian Pac J Cancer Prev; 2012; 13(7):3233-8. PubMed ID: 22994740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBMS3 at 3p24 inhibits nasopharyngeal carcinoma development via inhibiting cell proliferation, angiogenesis, and inducing apoptosis.
    Chen J; Kwong DL; Zhu CL; Chen LL; Dong SS; Zhang LY; Tian J; Qi CB; Cao TT; Wong AM; Kong KL; Li Y; Liu M; Fu L; Guan XY
    PLoS One; 2012; 7(9):e44636. PubMed ID: 22957092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.
    Yi Lo PH; Chung Leung AC; Xiong W; Law S; Duh FM; Lerman MI; Stanbridge EJ; Lung ML
    Cancer Lett; 2006 Mar; 234(2):184-92. PubMed ID: 15885884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.